enterosan

a glucosaminoglycan, which activates oxidization/reparative processes affecting intercellular space

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/01/2011 - "[Enterosan--perspective medications for patients with postinfection irritable bowel syndrome]." 01/01/2009 - "Biocorrection was held by organodrugs in particular by gepatosan and enterosan during chronic pancreatitis, cholelithiasis, alcoholic liver disease, irritable colon syndrome, viral hepatitises B, postcholecystectomy syndrome. "
2.	Chronic Pancreatitis 01/01/2009 - "Biocorrection was held by organodrugs in particular by gepatosan and enterosan during chronic pancreatitis, cholelithiasis, alcoholic liver disease, irritable colon syndrome, viral hepatitises B, postcholecystectomy syndrome. "
3.	Postcholecystectomy Syndrome (Sump Syndrome) 01/01/2009 - "Biocorrection was held by organodrugs in particular by gepatosan and enterosan during chronic pancreatitis, cholelithiasis, alcoholic liver disease, irritable colon syndrome, viral hepatitises B, postcholecystectomy syndrome. "
4.	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/01/2009 - "Biocorrection was held by organodrugs in particular by gepatosan and enterosan during chronic pancreatitis, cholelithiasis, alcoholic liver disease, irritable colon syndrome, viral hepatitises B, postcholecystectomy syndrome. "
5.	Inflammation (Inflammations) 01/01/2008 - "The use of enterosan decreases inflammation and activates regeneration in anastomosis area."